Therapeutic Advances in Neurological Disorders (Jan 2022)

Brain biopsy in patients with CLIPPERS syndrome: why and when? A case report and literature review

  • Imke Galazky,
  • Lars Büntjen,
  • Jürgen Voges,
  • I. Erol Sandalcioglu,
  • Christian Mawrin,
  • Aiden Haghikia

DOI
https://doi.org/10.1177/17562864211062821
Journal volume & issue
Vol. 15

Abstract

Read online

CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) is an inflammatory disorder of the central nervous system (CNS), predominantly involving the brainstem with a characteristic magnetic resonance imaging (MRI) appearance and clinical and radiological responsiveness to glucocorticosteroids. Yet diagnostic biomarkers are missing and other immune-mediated, (para-) infectious and malignant causes mimic CLIPPERS-like MRI presentations. We report the case of a 51-year-old male patient with CLIPPERS who repeatedly responded well to high-dose corticosteroids. After 7 months, however, treatment failed, and he had a biopsy-confirmed diagnosis of a CNS B-cell lymphoma. Clinical and MRI signs of CLIPPERS include a wide spectrum of differential diagnoses which often arise only later during the course of disease. Similar to the case presented here, delayed diagnosis and specific therapy may contribute to an unfavorable outcome. Hence, we propose that in the absence of other diagnostic markers, brain biopsy should be performed as early as possible in CLIPPERS patients.